Alessia D'alonzo

Genoa, 16132, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Survival Outcomes of Luminal Metastatic Breast Cancer Patients According to Changes in Molecular Subtype at Re-Biopsy: Insights from the GIM-13-AMBRA Study.

Survival Outcomes of Luminal Metastatic Breast Cancer Patients According to Changes in Molecular Subtype at Re-Biopsy: Insights from the GIM-13-AMBRA Study.

Journal: Cancers

Published: March 31, 2025

Practices and views about palliative care at the end of life: A survey of oncologists from the Italian region of Liguria.

Practices and views about palliative care at the end of life: A survey of oncologists from the Italian region of Liguria.

Journal: Tumori

Published: October 15, 2024

Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer.

Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer.

Journal: BMC palliative care

Published: August 01, 2023

T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study.

T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study.

Journal: Clinical breast cancer

Published: July 02, 2019

Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review.

Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review.

Journal: Clinical medicine insights. Reproductive health

Published: June 09, 2019

Management of young women with early breast cancer.

Management of young women with early breast cancer.

Journal: ESMO open

Published: October 14, 2018

Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study.

Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study.

Journal: Breast (Edinburgh, Scotland)

Published: April 11, 2018

Trastuzumab-related cardiotoxicity in patients with nonlimiting cardiac comorbidity.

Trastuzumab-related cardiotoxicity in patients with nonlimiting cardiac comorbidity.

Journal: The breast journal

Published: March 04, 2018

Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis.

Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis.

Journal: Breast (Edinburgh, Scotland)

Published: March 20, 2017

Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study.

Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study.

Journal: Oncotarget

Published: November 30, 2016

The PREgnancy and FERtility (PREFER) study: an Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients.

The PREgnancy and FERtility (PREFER) study: an Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients.

Journal: BMC cancer

Published: September 22, 2016

Treatment with aromatase inhibitors and markers of cardiovascular disease.

Treatment with aromatase inhibitors and markers of cardiovascular disease.

Journal: Breast cancer research and treatment

Published: July 24, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026